Brain immune cells carry Alzheimer-linked mutations
The brains of Alzheimer’s patients contain cells with DNA errors not found in healthy brains.
New research in Nature Aging examined what are called somatic variants in microglia-like cells. Somatic variants are DNA mutations that are not inherited but arise during a person’s lifetime in individual cells. The researchers analyzed brain tissue from people with and without Alzheimer’s disease and found a clear pattern: tissue from Alzheimer’s patients contained more of these mutations, and they were more often located in genes relevant to the disease.
Microglia are the brain’s immune cells. They clear harmful proteins, regulate inflammation, and play a central role in Alzheimer’s progression. If their DNA carries mutations that alter their function, that may compromise their ability to protect the brain. This would help explain why microglia perform poorly in Alzheimer’s patients.
Mutations as cause, not just consequence
The key question is the direction of causality. Earlier research focused mainly on inherited genetic risk factors. This study focuses on mutations that arise within cells over a lifetime. That makes it relevant to people without a family history of Alzheimer’s — the majority of patients.
The findings align with a broader idea in aging research: that the accumulation of somatic mutations over time contributes to cellular and tissue dysfunction. Here, the concern is not general body cells but specifically the immune cells that protect the brain.
What comes next?
If specific mutations in microglia contribute to Alzheimer’s, that opens new directions for early diagnostics. Which mutations appear in which individuals, and when? These are questions that new sequencing technologies are increasingly able to answer. Whether they are also therapeutically useful is still a distant step. But the research refines our picture of Alzheimer’s as a disease in which genetic instability in immune cells plays an active role.